GlassScriptPhysician profile
Ahmad K Saeed
NPI 1679087399
$5,688.46
in general payments reported to CMS, 2019-2025
19 companies · $2,779 in 2025
The $2,779 reported for 2025 was more than what 95% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $50.28 · 2023: $882 · 2024: $1,978 · 2025: $2,779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,273 · Education: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,272.79 |
| Education | $365.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,099.02 | 2023-2025 | |
| Janssen Biotech, INC. | $848.01 | 2023-2025 | Tremfya, Simponi Aria, Simponi |
| Regeneron Healthcare Solutions, INC. | $566.36 | 2023-2025 | Dupixent, Libtayo |
| Incyte Corporation | $563.84 | 2023-2025 | Opzelura, Opzelura, Iclusig |
| Genzyme Corporation | $463.90 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $375.52 | 2023-2025 | |
| Arcutis Biotherapeutics, INC. | $370.25 | 2024-2025 | Zoryve |
| Ucb, INC. | $266.64 | 2023-2025 | Bimzelx, Cimzia |
| Sun Pharmaceutical Industries INC. | $184.07 | 2022-2025 | Winlevi, Absorica Ld |
| Biofrontera INC. | $178.67 | 2025 | |
| Amgen INC. | $156.06 | 2024-2025 | Otezla, Otezla |
| Lilly USA, LLC | $141.97 | 2024-2025 | Ebglyss, Taltz |
| Leo Pharma INC. | $120.12 | 2023-2025 | Adbry, Anzupgo |
| E.R. Squibb & Sons, L.L.C. | $79.27 | 2022-2025 | Sotyktu |
| Dermavant Sciences, INC. | $67.49 | 2024 | Vtama |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $65.61 | 2024-2025 | |
| Galderma Laboratories, L.P. | $62.86 | 2024-2025 | Aklief, Nemluvio |
| Organon LLC | $54.08 | 2025 | Vtama |
| Verrica Pharmaceuticals INC. | $24.72 | 2025 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmad Saeed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.